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Abstract
Naevus count is the strongest risk factor for melanoma. Body Mass Index (BMI) has been
linked to melanoma risk. In this study, we investigate the link between naevus count and
height, weight and bone mineral density (BMD) in the TwinsUK cohort (N = 2119). In addi-
tion we adjusted for leucocyte telomere length (LTL) as LTL is linked to both BMD and
naevus count. Naevus count was positively associated with height (p = 0.001) but not with
weight (p = 0.187) despite adjusting for age and twin relatedness. This suggests that the
previously reported melanoma association with BMI may be explained by height alone. Fur-
ther adjustment for LTL did not affect the significance of the association between height and
naevus count so LTL does not fully explain these results. BMD was associated with naevus
count at the spine (coeff 18.9, p = 0.01), hip (coeff = 18.9, p = 0.03) and forearm (coeff =
32.7, p = 0.06) despite adjusting for age, twin relatedness, weight, height and LTL. This
large study in healthy individuals shows that growth via height, probably in early life, and
bone mass are risk factors for melanoma via increased naevus count. The link between
these two phenotypes may possibly be explained by telomere biology, differentiation genes
from the neural crests but also other yet unknown factors which may influence both bones
and melanocytes biology.
Introduction
Having a large number of benign melanocytic naevi is one of the strongest risk factors for ma-
lignant melanoma [1]. Twin studies have demonstrated that 60% of the variation in naevi num-
ber between individuals is genetically determined [2–4]. Naevi typically involutes after the
fourth decade of life in Caucasian populations and are rare in the elderly [3]. However,
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individuals who are susceptible to melanoma often have large numbers of naevi which persist
until middle age or later [5]. This suggests that reduced senescence in the melanocytic system
may be a good predictor of melanoma risk.
Telomere length is another important genetic marker of reduced senescence and melanoma
risk, as both naevi count and melanoma are associated with longer telomeres [6–8]. Telomere
length has been shown to have an impact on growth early in life especially in females [8]. Fur-
thermore, increased bone density is associated with leukocyte telomere length (LTL) [9]. De-
spite a clear association between higher body mass index (BMI) and some cancers [10–14] the
association with melanoma remains more controversial [15–18].
We therefore set out to examine at the relationships between naevus count, height, and
weight and bone density (BMD) with adjustments for LTL to explore the role of reduced senes-
cence and increased growth as a melanoma risk factor.
Materials and Methods
Twins UK
Twins were recruited from the TwinsUK adult twin registry. Caucasian monozygotic (MZ)
and dizygotic (DZ) twin pairs were enrolled in the study between 1992 and 2003 to assess the
heritability and genetics of age-related diseases (http://www.twinsUK.ac.uk). Members of
TwinsUK have been shown to have similar disease and lifestyle characteristic to the general
population and were not recruited on the basis of any specific trait or disease [19]. St. Thomas’
Hospital Research Ethics Committee approved the study, and all twins provided informed
written consent. All the data is available upon request from the Twin Research Unit website:
www.twinsuk.ac.uk/data-access/submission-procedure/.
Bone mineral density
All twins have been recruited since 1992. At each visit a variety of clinical investigations were
performed including bone mineral density (BMD) and weight measurement. Details of life-
style, medical and drug history were obtained from comprehensive nurse-administered ques-
tionnaires. Using questionnaire data, twins who received Hormone Replacement Therapy or
any osteoporosis treatment were excluded. BMD was measured at the lumbar spine (L1–4),
total hip and forearm using dual energy X-ray absorptiometry (DEXA) Hologic QDR4500W
(1996 to 2004). Daily quality control scans were performed using the spine phantom. All BMD
measurements were performed using a standardized protocol of measurement [6–9]. Twins
within each pair were always scanned at the same time. Intra-scanner reproducibility, express-
ed as a coefficient of variation from duplicate measurements in healthy volunteers one week
apart, was 0.8% at the lumbar spine and 1.6% at the femoral neck. Height, weight and body sur-
face area (BSA) was available on all twins.
Skin data
Skin examination and data collection was undertaken on 3648 twins between January 1995 and
December 2003. All twins underwent a skin examination including recording of skin type, hair
and eye colour, freckles and mole count on 17 body sites performed by 5 trained nurses at St
Thomas Hospital in London. This protocol for mole counting naevi has been published else-
where and has been validated in other studies [3,20,21]. Skin type was assessed according to
the Fitzpatrick classification.
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Telomere length
DNA was extracted from isolated leukocytes after an overnight fast and the mean leukocyte ter-
minal restriction fragment length (TRFL) was measured using the Southern blot method as de-
scribed previously [9]. Each DNA sample was resolved in duplicate (on different gels). If the
difference between the duplicates was>5%, a third measurement was done and the mean of
two results<5% apart was taken. This was only necessary in<5% of the assays. The coefficient
of variation of the TRFL assay in this study was 0.92%. The laboratory conducting the TRFL
measurements was blinded to all characteristics of the white cell donors.
Data summary
3648 twins had complete data on naevi count, height weight and clinical data. For BMD and
telomere length the data was restricted to 2119 subjects.
Statistical Methods
We used X2 Pearson’s test and Student’s t–test to compare categorical and continuous vari-
ables, respectively. Kruskall-Wallis test was used to analyze the differences between median in
non parametric analyses. Linear regression was used to calculate associations between naevus
count, BMD, telomere and other possible confounding factors. Multicollinearity between vari-
ables was tested with the variance inflation factor without significant results.
Logistic regressions were carried out to look at the association between number of naevi and
height. Number of naevi was categorized in groups of above or equal and below 50. Because of
the non independence of twins, we controlled for familial aggregation by treating twin-pairs as
clusters of information by using the robust regression cluster. Log likelihood ratio test was per-
formed for models comparisons and to select variables which have to be included in the final
models.
All statistical tests were two sided and p value0.05 were considered significant. The analy-
ses were performed in STATA 12 (StatCorp LP, College Station, TX, USA).
Results
2119 female Caucasian twins with naevus count, height, weight and measurements for BMD
at three sites (spine, forearm and hip) were included in this study. The mean age was
46.96±12.81 years (median 47.9 range 19–73 years). Regarding tanning ability, 12% had
Fitzpatrick skin type I, 33% type II, 35% type III and 20% type IV. The mean total body naevus
count was 34±41 (median 20-range 0 to 555). Naevus count was inversely correlated with
age as expected at linear regression (coeff. −0.67±0.05, p<0.0001). Mean height was
162.44±6.14 cm (median 162, IQ range 158–166) and mean weight was 66.79±12.53 kg (medi-
an 64.7). BMD was inversely correlated with age for all three sites at linear regression (coeff.
spine −21.16±1.46, coeff. forearm −62.47±3.78, coeff. hip −30.90±1.53, p<0.0001). BMD was
positively associated with both height and weight at linear regression (height coeff. spine
9.47±0.71, coeff forearm 20.95 ±1.83, coeff. hip 9.52±0.78, p<0.0001; weight coeff. spine
26.88±1.45, coeff forearm 54.03±3.99, coeff. hip 35.55±1.64, p<0.0001).
Although BMI was positively associated with BMD at linear regression (coeff. spine
7.17±0.55, coeff. forearm 13.75±1.48, coeff. hip 10.51±0.63, p<0.0001), it was not associated
with naevus count. When dissecting BMI, naevus count was positively associated with height
at linear regression (coeff. 0.39±.013, p = 0.003) (Fig. 1) but not weight even after adjusting for
twin relatedness, age and body surface area (BSA).
Growth and Melanoma
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Height was associated with naevus count in a multivariate linear model with further adjust-
ments for LTL. Therefore LTL does not explain fully the association observed between height
and an excess of naevi. Naevus count was categorized in two groups (above or equal to 50 and
below 50) for logistic regression evaluating the effect of increasing height on naevus count.
Height is positively associated with increasing number of naevi even after adjustment age and
twin relatedness. (Table 1).
BMD at the three sites was positively associated with total naevi count at univariate
analysis of linear regression (coeff spine37.05±4.95, coeff forearm 84.43±11.95, coeff hip
42.39±5.38<0.001) (Figs. 2–4). BMD at the spine, forearm and hip was positively correlated
with naevus count in linear regression analyses after adjusting for age, height, weight and twin
relatedness: (spine coeff. 19.85399±5.2925, p<0.001; forearm coeff. 35.34±12.52, p = 0.03; hip
coeff. 20.74619±6.12, p = 0.001). Further adjustments for telomere length did not affect the as-
sociation between naevi counts and BMD for spine and hip, whilst for the forearm it was no
Figure 1. Scatter plot for height (Y axis) in association with naevus count (X axis).
doi:10.1371/journal.pone.0116863.g001
Table 1. Logistic regression on risk factors for HNC (total naevus count equal or above 50) in
relation to increasing height. (Robust regression) (n = 2119).
HIGH NAEVUS COUNT (50) OR P value 95% IC
AGE 0.97 <0.001 0.96–0.97
HEIGHT (CM) <158 1
158–162 1.38 0.016 1.06–1.80
162.1–166 1.32 0.038 1.01–1.73
>166 1.67 <0.001 1.28–2.17
doi:10.1371/journal.pone.0116863.t001
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longer significant (spine coeff 18.90, p = 0.01, hip coeff = 18.9 p = 0.03 and forearm coeff =
32.67, p = 0.06) (Tables 2, 3, 4). BMI and BSA were not included in the final model for the obvi-
ous risk of collinearity.
Discussion
High number of naevi is the most powerful risk factor for melanoma and suggests a lack of se-
nescence in the melanocytes in individuals at high risk [7–8]. We report here a positive correla-
tion between the number of naevi and height after adjustment for age, weight and twin
relatedness. Weight alone is not associated with naevi counts in our study and is not a predictor
of melanoma risk.
The association between melanoma risk and BMI is controversial but previous studies have
already showed a link with higher BMI [15–18,22]. In this study, we dissected BMI by looking
at height and weight separately in relation to naevi count and showed that the association is
maintained with height but not weight. However, a melanoma case control study looked at
BMI, weight and height separately found an association between melanoma and weight but not
height in contrast to our study [22].
The study reported here also explored the association between naevus count and BMD and
showed a significant association at three sites. Spine BMD was the most significantly associated
with naevus count and this could be explained by the fact that the spine is a trabecular bone
and the rate of ageing is known to be greater in trabecular compared to cortical bones such as
hip and forearm [7].
Figure 2. Scatter plot for Spine BMD (Y axis) referred to naevus count (X axis).
doi:10.1371/journal.pone.0116863.g002
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The association between height and BMD and high naevus count suggests that growth is im-
portant for melanoma rather than weight alone. Height has already been reported to be a risk
factor for melanoma and other cancers [23–25]. Moreover height in childhood has already
been linked to breast cancer risk so it is likely that factors affecting growth early in life are in-
volved [26, 27]. The study reported here is looking at healthy individuals whom have not yet
developed cancer. This study confirms an association between height and risk of melanoma
using a powerful marker of risk phenotype for melanoma. Using naevus count allowed for the
recruitment of a large number of individuals to explore these associations which would be diffi-
cult for melanoma. The only confounding factor which affected the significance of the associa-
tion between BMD and naevi, apart from age, was height and LTL which suggests that it may
be a “growth/reduced senescence phenotype” which links naevi, telomere length and BMD as
risk factors for melanoma.
Though genetic make-up is a major determinant of height, modifiable early-life and pre-
pubertal factors, e.g., childhood nutrition, illness, and socioeconomic status are also relevant so
environmental factors may be at play as well [26]. Melanoma has already been associated with
higher socio-economical status and nutrition may be one of the factors involved [28, 29].
Bone loss is also considered an index of ageing so our findings of higher BMD in subjects at
risk of melanoma support the notion that the biological age of individuals with high naevus
count might be younger than their chronological age, in line with their longer LTL [9]. More-
over, telomere biology is likely to play an important role in the BMD-naevi count association.
However, despite adjusting for LTL, the association between naevi counts and BMD remained
so LTL does not explain it all. Naevi involute with age; a process which is likely to be, in part,
genetically driven [3–4]. However, the rate of at which naevi disappear with age varies greatly
Figure 3. Scatter plot for Forearm BMD (Y axis) in association with naevus count (X axis).
doi:10.1371/journal.pone.0116863.g003
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with some individuals still having a large number of naevi in late middle age. This phenomenon
is more likely to be observed in families at high risk of melanoma [5]. Oncogene (BRAF and
RAS) and tumour suppressor (p16, p14arf, p53, PTEN, Rb) driven cell senescence is important
in melanocytes [30–32]. PTEN depletion and the pI3K pathway are also thought to be impor-
tant in inhibiting BRAF induced senescence in naevi [33]. Telomere erosion as well genes in
the p53 pathways also play a role in cell senescence [34–35]. However, examining markers of
senescence does not differentiate benign naevi from melanoma so does not allow speculation
of which factors influence progression from naevus to melanoma [36].
Similarly bone loss with age varies widely between individuals with levels of post-meno-
pausal bone loss estimated between 0.5% and 3% per annum [37]. Fifty per cent of the variance
in bone loss in postmenopausal Caucasian women is due to genetic factors [38]. Like naevus
count, BMD has also been positively linked to LTL [16]. Interestingly, osteoblasts and melano-
blasts originate from the neural crest [38, 39]. A complex network of genes and pathways are
Figure 4. Scatter plot for hip BMD (Y axis) in association with naevus count (X axis).
doi:10.1371/journal.pone.0116863.g004
Table 2. Multivariate Linear Regression for the association between naevus count and spine BMD.
(Robust regression) (n = 2119).
NAEVUS COUNT COEFF P VALUE 95%CI
SPINE BMD 18.90 0.013 3.94 33.86
AGE −.43 0.000 −.59 −.26
TELOMERE LENGHT 3.82 0.005 .1.15 6.48
HEIGHT .42 0.010 .10 .74
WEIGHT .02 0.850 −.15 .18
doi:10.1371/journal.pone.0116863.t002
Growth and Melanoma
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involved in cell differentiation and migration. Among these genes MITF, WNT/beta Catenin,
SOX9, SOX2, PAX3, RANK/RANKL are important in melanocyte differentiation and melano-
ma [40,41]. Recent GWAS studies of osteoporosis have identified variants in many of the
above genes as predictors of bone density [40–47]. There is therefore substantial evidence that
many genes involved in bone metabolism are also crucial for melanocyte differentiation and in-
vasion. Curves showing rates of bone loss and decrease in naevus count with age in this study
are very similar supporting the hypothesis that factors determining the rate of ageing for these
two phenotypes are likely to be linked.
This study shows an association between height, BMD and naevus count which are all influ-
enced by LTL and supports the role of telomere biology in melanoma [6]. However, LTL does
not explain the whole of these associations so other factors are at play. SNPs in the TERT gene
and amplification in its promoter have been to linked to melanoma risk in recent studies
[7,36,48–50]. The reduced senescence generated by longer LTL may have positive offsets in in-
dividuals at higher risk of melanoma with protection against osteoporosis and possibly other
ageing phenotypes. Unfortunately, it is also likely to explain the observed increased risk of can-
cers (not only melanoma) in many families with an excess of naevi (especially in the presence
of many atypical naevi). This shows the intricate balance between ageing and cancer as
highlighted by Peeper et al [10]. Results of GWAS candidates for osteoporosis, BMI and telo-
mere length are currently being investigated as possible candidates for naevi counts to discover
new naevi/melanoma genes. However, recent GWAS for height and BMD are currently being
reported with increasing sample size (as many as 250,000 individuals for height) showing very
large numbers of SNPs variants for height (more than 600 SNPs to date) and BMD so the task
is not easy. Genome-wide association studies have shown that many of the genes associated to
height are linked to cancer pathways [51].
It is likely therefore that the connections reported here between naevus counts, height and
BMD could be explained by a large network of genes involved in embryogenesis, development
and growth which later may have an impact on cancer risk, especially genes involved in the
common stem cell lineage shared by melanocytes and bone cells in the neural crest.
Table 3. Multivariate Linear Regression for the association between naevus counts and hip BMD.
(Robust regression) (n = 2119).
NAEVUS COUNT COEFF P VALUE 95%CI
HIP BMD 18.96 0.03 1.49 36.44
AGE −.42 0.000 −.59 −.25
TELOMERE LENGHT 3.86 0.005 .1.17 6.55
HEIGHT .44 0.16 .13 .77
WEIGHT .004 0.961 −.17 .18
doi:10.1371/journal.pone.0116863.t003
Table 4. Multivariate Linear Regression for the association between naevus count and forearm BMD
(Robust regression) (n = 2119).
NAEVUS COUNT COEFF P VALUE 95%CI
FOREARM BMD 32.67 0.06 −2.14 67.48
AGE −.44 0.000 −.61 −.28
TELOMERE LENGHT 3.77 0.005 1.11 6.44
HEIGHT .44 0.008 .11 .76
WEIGHT .04 0.619 −.12 .20
doi:10.1371/journal.pone.0116863.t004
Growth and Melanoma
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